Biogen | BIIB - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 72M 10M 2025-09
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
ALKERMES USD 11.94M 853K 2025-09
Bayer EUR 130M 38M 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Gilead Sciences USD 88M 15M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Merck USD 96M 27M 2025-09
Moderna USD 73M 8M 2025-09
Pfizer USD 0.62 156M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09